European Companies Search Engine
Earnings statement for 31/12/2019 Rikf12 Oct 2020 Registrite ja Infosüsteemide Keskus (financials), Estonia
Overview
Text
| Currency: EUR | ||
| Date | 2019-12-31 | 2018-12-31 |
| Operating profit/loss | 0.0 | 0.0 |
| -Revenue | 0.0 | 0.0 |
| -Change in finished goods & WIP inventories | 0.0 | 0.0 |
| -Capitalised own work | 0.0 | 0.0 |
| -Other operating income | 0.0 | 0.0 |
| -Change in agricultural produce inventories | 0.0 | 0.0 |
| -Profit/loss from biological assets | 0.0 | 0.0 |
| -Goods, materials and services | 0.0 | 0.0 |
| -Total labor costs | 0.0 | 0.0 |
| --Salaries | 0.0 | 0.0 |
| --Social taxes | 0.0 | 0.0 |
| --Pensions | 0.0 | 0.0 |
| --Other staff costs | 0.0 | 0.0 |
| -Depreciation & impairment of non-current assets | 0.0 | 0.0 |
| -Significant write-downs of current assets | 0.0 | 0.0 |
| -Other business expenses | 0.0 | 0.0 |
| -Miscellaneous operating expenses | 0.0 | 0.0 |
| Finance income/expenses from shares in subsidiaries | 0.0 | 0.0 |
| Finance income/expenses from shares in associates | 0.0 | 0.0 |
| Other finance income and expenses | 0.0 | 0.0 |
| Interest income | 0.0 | 0.0 |
| Interest expense | 0.0 | 0.0 |
| Profit/loss from subsidiaries and associates | 0.0 | 0.0 |
| Profit/loss from financial investments | 0.0 | 0.0 |
| Profit/loss before tax | 0.0 | 0.0 |
| Income tax | 0.0 | 0.0 |
| Net profit/loss | 0.0 | 0.0 |
| Grant income related to assets | 0.0 | 0.0 |
| Depreciation/impairment of grant-financed assets | 0.0 | 0.0 |
| Profit/loss for the reporting year in the case of the net method of targeted financing | 0.0 | 0.0 |
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: MM Pharma OÜ, Tallinn, Estonia.
